These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 5618970)

  • 1. [Antilipemics and atherosclerosis].
    Chiche P; Chekler P; Ribadeau-Dumas JL; Derrida R
    Coeur Med Interne; 1967 Apr; 6(2):235-43. PubMed ID: 5618970
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current trends in the therapy of arteriosclerotic disease].
    Toscano S
    G Clin Med; 1974 Jan; 55(1):27-39. PubMed ID: 4369524
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention and treatment of arteriosclerosis.
    DePalma RG
    Compr Ther; 1992 Feb; 18(2):30-2. PubMed ID: 1547601
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thiadenol in the short-term treatment of patients with blood lipid disorders].
    Di Stefano F; Patane S; Gatto A
    Minerva Med; 1980 Mar; 71(8):567-74. PubMed ID: 7360386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypolipidemic, hypocholesterolemic and antisclerotic action of the rotenoid glycoside amorphin].
    Kurmukov AG; Aĭzikov MI; Rasulova SA; Makhmudov OKh
    Farmakol Toksikol; 1986; 49(6):54-7. PubMed ID: 3817147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of coronary arteriosclerosis depending on the nature of lipid metabolism disorders].
    Anisimov VE; Semavin IE
    Klin Med (Mosk); 1975 Jul; 53(7):66-9. PubMed ID: 1206996
    [No Abstract]   [Full Text] [Related]  

  • 7. When to treat raised lipids.
    Jolleys J
    Practitioner; 1999 Jun; 243(1599):510-3, 515-6. PubMed ID: 10476570
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of hyperlipidemia].
    Müller G
    Dtsch Gesundheitsw; 1971 Oct; 26(43):2020-4. PubMed ID: 4947270
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypolipemic effects of a new tetralin derivative: compound 13473-Su (Ciba)].
    Ciobanu V; Zălaru MC; Ciocan A; Mihăilescu S
    Stud Cercet Med Interna; 1971; 12(1):67-80. PubMed ID: 5565781
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of atherosclerosis with hypolipidemic and antiuricemic agents].
    Plastinina RA; Oleĭnik NA; Valeeva RM; Pavlova TN
    Sov Med; 1984; (1):83-7. PubMed ID: 6701660
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipids and their role in coronary heart disease: what they do and how to manage them.
    Pradka LR
    Nurs Clin North Am; 2000 Dec; 35(4):981-91. PubMed ID: 11072283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of hypolipidaemic agents in the fight against atherosclerosis (author's transl)].
    Jacotot B
    Nouv Presse Med; 1980 Oct; 9(40):2951-4. PubMed ID: 7443429
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperlipidemia management in patients with cardiovascular and cerebrovascular disease.
    J Fla Med Assoc; 1998 Apr; 85(1):26-8. PubMed ID: 9782725
    [No Abstract]   [Full Text] [Related]  

  • 14. Warfarin metabolism during ethyl chlorophenoxyisobutyrate treatment.
    Pyörälä K; Ristola P; Myllylä G
    Ann Med Intern Fenn; 1968; 57(4):157-60. PubMed ID: 5731345
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sulodexide in the therapy of vasculopathies].
    Postiglione F; Pisani P; Gisonni P; Perrotta P; Gisonni A; Canciello M; Napolitano L; Brighina G; Ragno I; Salzano A
    Clin Ter; 1986 May; 117(3):223-31. PubMed ID: 3524974
    [No Abstract]   [Full Text] [Related]  

  • 16. Classification of primary hyperlipidemia. Observations on 214 patients.
    Schatz IJ
    JAMA; 1969 Oct; 210(4):701-4. PubMed ID: 5394402
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug therapy for hyperlipidemia.
    Franklin FA; Margolis S
    Cardiovasc Clin; 1984; 14(3):265-84. PubMed ID: 6722855
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of lipemia-lowering agents in the secondary prevention of myocardial infarct].
    Tullio D
    Clin Ter; 1986 Feb; 116(3):221-35. PubMed ID: 3516543
    [No Abstract]   [Full Text] [Related]  

  • 19. [The possible means for the pharmacological correction of lipid metabolic disorders in atherosclerosis].
    Piskun RP; Pentiuk AA; Serkova VK; Polesia TL; Savitskaia EA
    Eksp Klin Farmakol; 1997; 60(2):78-85. PubMed ID: 9206580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of disorders of the lipid metabolism which carry the risk of arteriosclerosis].
    Kopp H
    MMW Munch Med Wochenschr; 1978 May; 120(21):739-40. PubMed ID: 306554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.